市場調査レポート

医薬品業界向けナノパッケージング:世界的技術・産業・市場分析

Nano-Enabled Packaging for the Pharmaceutical Industry - A Global Technology, Industry and Market Analysis

発行 Innovative Research and Products (iRAP) 商品コード 116858
出版日 ページ情報 英文 93 Pages
納期: 即日から翌営業日
価格
こちらの商品の販売は終了いたしました。
Back to Top
医薬品業界向けナノパッケージング:世界的技術・産業・市場分析 Nano-Enabled Packaging for the Pharmaceutical Industry - A Global Technology, Industry and Market Analysis
出版日: 2010年03月30日 ページ情報: 英文 93 Pages

当商品の販売は、2016年07月01日を持ちまして終了しました。

概要

医薬品業界におけるパッケージングはこの10年で大きく様変わりしました。水分や光、酸素から守る保護機能に留まらず、現在のパッケージングデザインはドラッグデリバリープロセスにおいて重要な役割を担い、薬剤の安全性に貢献しています。

当レポートでは、医薬品業界におけるナノパッケージングの現状について理解し、市場の機会や参入企業、求められる技術と知的財産動向をまとめ、概略下記の構成でお届けいたします。

イントロダクション

エグゼクティブサマリー

産業概要

  • 業界参入企業
    • 応用別
    • 技術別
    • 地域別
  • 市場セグメント
  • 規制問題

技術概要

  • パッケージング技術
    • アクティブパッケージング
    • 高酸化化合物の取扱
    • 水分管理
    • 薬剤処方のための保護
    • 適切なパッケージングソリューションの入手
    • スマートパッケージング
    • 偽装防止
    • 薬剤適合性
  • パッケージングの応用
    • ブリスターパック
    • コンテナー
    • プラスチックボトル
    • パウチ・ストリップ
    • アクセサリ・封止剤
  • パッケージング材料
    • アルミニウムフォイル
    • ナノ薄膜
    • コーティング剤
  • 将来動向

市場分析

  • 世界の産業
  • 合併・買収
  • 世界市場
    • 北米
    • 欧州
    • アジア太平洋諸国
    • 中国

特許および特許分析

  • 特許リスト
  • 特許分析

企業プロファイル

図表

目次
Product Code: PH-101

Abstract

Packaging in the pharmaceutical industry has gone through major changes in the past decade. The advent of new drug delivery systems and the development of new biochemical compounds have resulted in a need not only for enhanced protection against factors such as moisture, light, oxygen and mechanical forces, but also for packaging forms to play a more integral role in the drug delivery process. Packaging design today provides stability and shelf life to the drug and the delivery system, which becomes fundamental to the safety, convenience and compliance of drug use.

Nanotechnology, the science of very small materials, is poised to have a big impact in pharmaceutical packaging. Basic categories of nanotechnology applications and functionalities appear in development of pharmaceutical (or pharma) packaging in terms of enhancement of plastic materials' barriers; incorporation of active components that can deliver functional attributes beyond those of conventional active packaging; and sensing and signaling of relevant information.

study goal and objectives

The study is intended to benefit existing manufacturers of pharmaceuticals who seek to expand market opportunities. It also can serve as a reference for pharma packaging industry players who would like to expand to nano-enabled technologies for drug packaging. This study also provides the most complete accounting of nano-enabled packaging of pharmaceutical products in various markets around the globe.

The main objective of this report is to understand the current state of nano-enabled packaging in the pharmaceutical industry, market opportunities, the companies involved, technologies being pursued and intellectual property (IP) trends.

This study covers various aspects of nano-enabled packaging, providing data about the size and growth of application segments, industry trends, new developments including a detailed patent analysis, and company profiles. Another goal of this report is to provide a detailed and comprehensive multi-client study of the market in North America, Europe, Asia Pacific and the rest of the world for nano-enabled packaging, as well as potential business opportunities emerging in the future.

The study objectives include thorough coverage of the underlying economic issues driving the nano-enabled packaging business, as well as assessments of new advanced nano-enabled packaging that are being developed. Particular attention was paid to providing realistic market data and forecasts for the nano-enabled packaging industry segments. This study provides the most thorough and up-to-date assessment that can be found anywhere on the subject. The study also provides extensive quantification of the many important facets of market developments in nano-enabled packaging all over the world. Ultimately, the study contributes to the determination of the kinds of strategic responses that can be adopted by companies hoping to compete in this dynamic market.

REASONS FOR DOING THE STUDY

In the pharmaceutical industry, there is an ever growing emphasis on security, as well as on patient convenience and greater automation, without compromising quality or safety standards. Increasing importance has been placed on the role that packaging plays in establishing brand preference.

The role of packaging in pharmaceuticals has taken an incremental leap forward in terms of its critical importance as an integral part of the product. New packaging solutions will focus more on drug safety by controlling microbial growth, delaying oxidation, improving tamper visibility and enhancing convenience. Therefore, iRAP felt a need to do a detailed market update and analysis for this industry.

Contributions of the study

This study provides the most complete accounting of the nano-enabled pharma packaging market growth in North America, Europe, Asia Pacific and the rest of the world currently available in a multi-client format. It provides the most thorough and up-to-date assessment that can be found anywhere on the subject and includes extensive quantification of the many important facets of market developments in various markets for nano-enabled pharma packaging. This quantification, in turn, contributes to the determination of strategic responses that suppliers may adopt in order to compete in these dynamic markets. Audiences for this study include marketing executives, business unit managers and other decision makers in the pharma packaging companies, as well as in companies peripheral to this business.

SCOPE AND FORMAT

The market data contained in this report quantifies opportunities for nano-enabled packaging technologies, nanomaterials used for packaging, and technology applications. In addition to product types, it also covers the merits and future prospects of the nano-enabled pharma packaging business. It also covers in detail the economic and regulatory issues regarded by many as critical to the industry' s current state of change. The report provides a review of the nanotechnologies involved in the pharma packaging industry, its structure, and the companies involved in providing these packaged products.

TO WHOM THE STUDY CATERS

The report provides the most thorough and up-to-date assessment that can be found anywhere on the subject. The study is intended to benefit current pharma packaging producers and users as well as developers of new technologies in this area. Specifically, the report would be of great use to:

  • producers and suppliers of pharma packaging;
  • suppliers of pharma packaging materials;
  • resin supplier;
  • producers and suppliers of nanoparticles;
  • users of pharma packaging;
  • universities and research institutions involved in research in the pharma packaging area; and investors and venture capitalists interested in new technology areas.

REPORT SUMMARY

Packaging in the pharmaceutical industry has gone through major changes in the past decade. The advent of new drug delivery systems and the development of new biochemical compounds have resulted in a need not only for enhanced protection against factors such as moisture, light, oxygen and mechanical forces, but also for packaging forms to play a more integral role in the drug delivery process.

Nanotechnology is poised to have a big impact in pharmaceutical packaging and will enable it to bring innovative and new generation packaging solutions to market. The addition of certain nanoparticles into shaped objects and films has been shown to render them light, fire-resistant and stronger in terms of mechanical and thermal performance, as well as less permeable to gases. Thus, it is possible to make new packaging solutions that focus more on drug safety by controlling microbial growth and delaying oxidation as well as improving tamper visibility and anti-counterfeiting.

As nanotechnology meets the new demands of pharma packaging, there are opportunities for tremendous growth in next few years. To clearly understand the landscape and undercurrents, the nano-enabled packaging for pharma industry has been segmented by:

  • technology - active and smart packaging;
  • pharma packaging applications - blisters, containers, bottles, pouches, syringes etc.; and
  • market regions - namely, North America, Latin America, Europe (including Russia), Asia Pacific and China.

The total market for nano-enabled packaging for pharma is $3.8 billion in 2009, which is expected to grow to $8.1 billion by 2014, at a compound annual growth rate (CAGR) of 16.48% from 2009 to 2014.

Other major findings of this report are:

  • The U.S. and Europe will remain the largest consumers of pharmaceutical packaging, as their advanced drug-producing sectors introduce new therapies with specialized packaging needs.
  • The North America market for nano-enabled packaging in pharma will grow from $1.08 billion in 2008 to $2.03 billion by 2014. The European market will grow from $1.15 billion in 2008 to $1.46 billion in 2014.
  • Japan continues to have the major share of the Asia Pacific market (65%), but its share is expected to decrease as India evolves into a fast-growing pharmaceutical packaging market as drug-producing sectors are upgraded and diversified, especially in the area of generic drugs.

China' s growth opportunities will be among the strongest, based on rapidly expanding pharmaceutical manufacturing capabilities there and the phasing-in of a government program designed to upgrade the quality and integrity of nationally produced medicines.

Table of Contents

INTRODUCTION

  • STUDY GOAL AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • CONTRIBUTIONS OF THE STUDY
  • SCOPE AND FORMAT
  • METHODOLOGY
  • INFORMATION SOURCES
  • WHOM THE STUDY CATERS TO
  • AUTHOR' S CREDENTIALS

EXECUTIVE SUMMARY

  • SUMMARY TABLE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
  • SUMMARY FIGURE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2009 AND 2014

INDUSTRY OVERVIEW

  • INDUSTRY PLAYERS
  • TABLE 1 COMPANIES IN NANO ENABLED PACKAGING FOR PHARMA
  • MARKET SEGMENTS
  • MARKET BY APPLICATION TYPES
  • MARKET BY APPLICATION TYPES (CONTINUED)
  • TABLE 2 MARKET FOR NANO ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2008, 2009 AND 2014 ($ BILLIONS)
  • FIGURE 1 MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2009 AND 2014
  • MARKET BY TECHNOLOGY
  • TABLE 3 MARKET FOR NANO ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
  • FIGURE 2 MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2009 AND 2014
  • MARKET BY REGION
  • MARKET BY REGION (CONTINUED)
  • TABLE 4 MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY REGIONS, 2008, 2009 AND 2014
  • FIGURE 3 MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY REGIONS, 2009 AND 2014
  • REGULATORY ISSUES

TECHNOLOGY OVERVIEW

  • PACKAGING TECHNOLOGY
  • ACTIVE PACKAGING
  • HANDLING HIGHLY OXIDATIVE COMPOUNDS
  • HANDLING HIGHLY OXIDATIVE COMPOUNDS
  • (CONTINUED)
  • MOISTURE CONTROL
  • PROTECTION FOR DRUG FORMULATIONS
  • PROTECTION FOR DRUG FORMULATIONS
  • (CONTINUED)
  • GETTING THE RIGHT PACKAGING SOLUTION
  • SMART PACKAGING
  • TAMPERING AND COUNTERFEITING
  • TAMPERING AND COUNTERFEITING (CONTINUED)
  • DRUG COMPLIANCE
  • DRUG COMPLIANCE (CONTINUED)
  • DRUG COMPLIANCE (CONTINUED)
  • TABLE 5 NEW COMPLIANCE PRODUCT INTRODUCTIONS
  • PACKAGING APPLICATION TYPES
  • BLISTER PACKS
  • BLISTER PACKS (CONTINUED)
  • CONTAINERS (INHALERS AND SYRINGES)
  • PLASTIC BOTTLES
  • POUCHES AND STRIPS
  • ACCESSORIES AND CLOSURES
  • PACKAGING MATERIAL TYPES
  • SECURED ALUMINUM FOIL
  • NANO-ENABLED THIN FILMS
  • NANO-ENABLED THIN FILMS (CONTINUED)
  • COATINGS
  • FUTURE TRENDS
  • FUTURE TRENDS (CONTINUED)

MARKET ANALYSIS

  • GLOBAL INDUSTRY
  • MERGERS AND ACQUISITIONS
  • TABLE 6 PACKAGING-RELATED MERGERS AND ACQUISITIONS IN THE PHARMA INDUSTRY (2004-2009)
  • TABLE 6 PACKAGING-RELATED MERGERS AND ACQUISITIONS IN THE PHARMA INDUSTRY, 2004-2009 (CONTINUED)
  • GLOBAL MARKETS
  • NORTH AMERICA
  • TABLE 7 NORTH AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
  • FIGURE 4 NORTH AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2009 AND 2014
  • TABLE 8 NORTH AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2008, 2009 AND 2014 ($
  • BILLIONS)
  • FIGURE 5 NORTH AMERICA MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2009 AND 2014
  • LATIN AMERICA
  • TABLE 9 LATIN AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
  • FIGURE 6 LATIN AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2009 AND 2014
  • TABLE 10 LATIN AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2008, 2009 AND 2014 ($
  • BILLIONS)
  • FIGURE 7 LATIN AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2009 AND 2014
  • EUROPE
  • TABLE 11 EUROPEAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014 ($ BILIONS)
  • FIGURE 8 EUROPEAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2009 AND 2014
  • TABLE 12 EUROPEAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2008, 2009 AND 2014
  • FIGURE 9 EUROPEAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2009 AND 2014
  • ASIA-PACIFIC
  • TABLE 13 ASIA-PACIFIC MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
  • FIGURE 10 ASIA-PACIFIC MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2009 AND 2014
  • TABLE 14 ASIA-PACIFIC MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2008, 2009 AND 2014 ($ BILLIONS)
  • FIGURE 11 ASIA-PACIFIC MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2009 AND 2014
  • CHINA
  • TABLE 15 CHINESE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
  • FIGURE 12 CHINESE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2009 AND 2014
  • TABLE 16 CHINESE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2008, 2009 AND 2014 ($ BILLIONS)
  • FIGURE 13 CHINESE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2009 AND 2014

PATENTS AND PATENT ANALYSIS

  • LIST OF PATENTS
  • HIGH STABILITY PACKAGE FOR DENTAL TREATMENT DEVICES
  • SORBENT CANISTER WITH BEVELED EDGES
  • CHILD-RESISTANT COMPACT FOR BLISTER CARD PRODUCTS
  • THREADED CHILD-RESISTANT PACKAGE HAVING LINERLESS
  • CLOSURE
  • CHILD-RESISTANT ONE-PIECE PUSH AND TURN CLOSURE
  • HUMIDITY CONTROL DEVICE
  • CLOSURE AND CONTAINER PACKAGE WITH RFID CIRCUIT
  • PLASTIC PACKAGING HAVING A MARKER MATERIAL
  • CHILD-RESISTANT TAMPER-INDICATING PACKAGE
  • POLYACRYLIC FILM FORMING COMPOSITIONS
  • CHILD-RESISTANT FLIP-TOP DISPENSING CLOSURE AND PACKAGE
  • CLOSURE AND PACKAGE HAVING CHILD-RESISTANT AND NON-CHILD-RESISTANT MODES OF OPERATION
  • CLOSURE AND PACKAGE WITH INDUCTION SEAL AND RFID TAG
  • MONITORING OBJECT MOVEMENT
  • CHILD-RESISTANT CONTAINER AND CAP
  • OXYGEN-ABSORBING COMPOSITIONS AND METHOD
  • DEACTIVATING A DATA TAG FOR TAMPER-EVIDENT PACKAGING
  • ACID-GAS ABSORBING TABLET AND METHOD OF USE
  • PACKAGING AND DELIVERY OF PHARMACEUTICALS AND DRUGS
  • RECLOSEABLE BIOSENSOR
  • PACKAGING FILM, PACKAGE AND PROCESS FOR ASEPTIC PACKAGING
  • METHOD AND PACKAGING FOR PRESSURIZED CONTAINERS
  • SORBENT CAPSULE
  • OXYGEN-ABSORBING COMPOSITION
  • TAMPER-INDICATING BAND ARRESTER
  • PRESSED ADSORBENT AND METHOD OF FABRICATION THEREOF
  • CHILD-RESISTANT DISPENSER
  • INTERACTIVE INFORMATION PACKAGE
  • DISPENSING CLOSURE
  • SELF-RETAINING ADSORBENT UNIT
  • PHARMACEUTICAL KIT FOR OXYGEN-SENSITIVE DRUGS
  • OXYGEN SCAVENGING COMPOSITIONS FOR PACKAGING APPLICATIONS
  • ONE-HAND OPENING CHILD-RESISTANT BLISTER PACK CONTAINER
  • PHARMACEUTICAL KIT FOR OXYGEN-SENSITIVE DDRUGS
  • DISPENSING UNIT FOR OXYGEN-SENSITIVE DRUGS
  • PATENT ANAYLSIS
  • TABLE 17 NUMBER OF U.S. PATENTS GRANTED TO COMPANIES IN THE OXYGEN SCAVENGING CATEGORY FROM 2004 THROUGH 2008
  • FIGURE 14 TOP COMPANIES GRANTED U.S. PATENTS FOR BARRIER PACKAGING IN PHARMA FROM 2004 THROUGH 2008

COMPANY PROFILES

  • AARDEX LTD
  • ABR PHARMA
  • ALCOA FLEXIBLE PACKAGING
  • ALCAN PACKAGING
  • ALLPLAS EMBALAGENS, LTDA
  • AMCOR FLEXIBLES WINTERBOURNE
  • AMERISOURCE BERGEN CORPORATION
  • AMPAC PACKAGING, LLC
  • ANDERSON PACKAGING INC
  • ASTRA ZENECA PLC
  • BANG & OLUFSEN MEDICOM
  • BILCARE LIMITED
  • BOSCH PACKAGING TECHNOLOGY
  • BRISTOL-MYERS SQUIBB CO
  • BURGOPAK LTD
  • CARDINAL HEALTH, INC
  • COLBERT PACKAGING
  • CSP TECHNOLOGIES, INC
  • CRYOPAK INDUSTRIES
  • CRYOVAC SEALED AIR CORPORATION
  • CURWOOD, INC
  • CYPAK AB
  • DRAGON INTERNATIONAL GROUP CORP
  • ECOBLISS-PHARMA
  • GERRESHEIMER
  • GLAXOSMITHKLINE PLC
  • HONEYWELL INTERNATIONAL INC
  • INEOS FILMS INC
  • INFORMATION MEDIARY CORPORATION
  • KIMBERLY-CLARK HEALTH CARE
  • KLOCKNER PENTAPLAST
  • MCNEIL CONSUMER HEALTHCARE
  • MEADWESTVACO CORPORATION (MWV)
  • MENASHA CORPORATION
  • MERCK
  • MULTISORB TECHNOLOGIES, INC
  • NEOPAC
  • PACKSHIELD
  • PERFECSEAL LTD
  • REXAM CLOSURES
  • ROCHE DIAGNOSTICS CORPORATION
  • SCHOTT NORTH AMERICA, INC
  • STORA ENSO
  • SUD-CHEMIE AG
  • SUPERFOS A/S
  • TEKNI-FILMS U.S
  • THERMO FISHER SCIENTIFIC INC
  • UNITED DRUG PLC
  • WYETH CONSUMER HEALTHCARE, INC

LIST OF TABLES

  • SUMMARY TABLE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
  • TABLE 1 COMPANIES IN NANO ENABLED PACKAGING FOR PHARMA
  • TABLE 2 MARKET FOR NANO ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2008, 2009 AND 2014 ($ BILLIONS)
  • TABLE 3 MARKET FOR NANO ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
  • TABLE 4 MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY REGIONS, 2008, 2009 AND 2014
  • TABLE 5 NEW COMPLIANCE PRODUCT INTRODUCTIONS
  • TABLE 6 PACKAGING-RELATED MERGERS AND ACQUISITIONS IN THE PHARMA INDUSTRY (2004-2009)
  • TABLE 6 PACKAGING-RELATED MERGERS AND ACQUISITIONS IN THE PHARMA INDUSTRY, 2004-2009 (CONTINUED)
  • TABLE 7 NORTH AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
  • TABLE 8 NORTH AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2008, 2009 AND 2014 ($ BILLIONS)
  • TABLE 9 LATIN AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
  • TABLE 10 LATIN AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2008, 2009 AND 2014 ($ BILLIONS)
  • TABLE 11 EUROPEAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014 ($ BILIONS)
  • TABLE 12 EUROPEAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2008, 2009 AND 2014
  • TABLE 13 ASIA-PACIFIC MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
  • TABLE 14 ASIA-PACIFIC MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2008, 2009 AND 2014 ($ BILLIONS)
  • TABLE 15 CHINESE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2008, 2009 AND 2014 ($ BILLIONS)
  • TABLE 16 CHINESE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2008, 2009 AND 2014 ($ BILLIONS)
  • TABLE 17 NUMBER OF U.S. PATENTS GRANTED TO COMPANIES IN THE OXYGEN SCAVENGING CATEGORY FROM 2004 THROUGH 2008

LIST OF FIGURES

  • SUMMARY FIGURE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2009 AND 2014
  • FIGURE 1 MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2009 AND 2014
  • FIGURE 2 MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2009 AND 2014
  • FIGURE 3 MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY REGIONS, 2009 AND 2014
  • FIGURE 4 NORTH AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2009 AND 2014
  • FIGURE 5 NORTH AMERICA MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2009 AND 2014
  • FIGURE 6 LATIN AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2009 AND 2014
  • FIGURE 7 LATIN AMERICAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2009 AND 2014
  • FIGURE 8 EUROPEAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2009 AND 2014
  • FIGURE 9 EUROPEAN MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2009 AND 2014
  • FIGURE 10 ASIA-PACIFIC MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2009 AND 2014
  • FIGURE 11 ASIA-PACIFIC MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2009 AND 2014
  • FIGURE 12 CHINESE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY TECHNOLOGY, 2009 AND 2014
  • FIGURE 13 CHINESE MARKET FOR NANO-ENABLED PACKAGING FOR PHARMA BY APPLICATION TYPE, 2009 AND 2014
  • FIGURE 14 TOP COMPANIES GRANTED U.S. PATENTS FOR BARRIER PACKAGING IN PHARMA FROM 2004 THROUGH 2008
Back to Top